Abstract
The goiter prevalence in iodine-deficient regions is up to 25%–54%. The most frequent disease in these endemic areas is non-toxic goiter, which is, however, oftentimes connected with autonomously functioning thyroid tissue leading to borderline or overt hyperthyroidism. Other thyroid diseases like cancer, thyroiditis and hypothyroidism play only a minor role in a thyroid clinic, while cases of Graves' disease may be observed more frequently. The most cost-effective tools to evaluate thyroid patients are the hand, ear and mouth of the thyroid clinician. The differential diagnosis of thyroid disorders may be evaluated by a battery of diagnostic tools like in-vitro tests and high performance imaging modalities. Once the diagnosis is established, the appropriate therapeutic procedures (drugs, radioiodine, surgery) have to be chosen. This review should be considered as a guideline for the diagnosis and treatment of thyroid diseases. In addition, special problems concerning elderly patients and pregnant women are discussed, including the differential diagnosis of thyroid diseases.
Similar content being viewed by others
References
Ahmann AJ, Solomon B, Duncan WI, Wartofsky L (1987) Normal bone mineral density (BMD) in premenopausal women on suppressive doses ofl-thyroxine. Abstract 41, American Thyroid Association 62nd Meeting, Washington
Attie JN (1988) Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer 24:315–324
Baker BA, Gharib H, Markowitz H (1983) Correlation of thyroid antibodies and cytologic features in suspected autoimmune thyroid disease. Am J Med 74:941–944
Bastenie PA, Bonnyns M, Van Haelst L (1980) Grades of subclinical hypothyroidism on asymptomatic autoimmune thyroiditis revealed by the thyrotropin releasing hormone test. J Clin Endocrinol Metab 51:163–166
Bayer MF (1987) Performance criteria for appropriate characterization of “(highly) sensitive” thyrotropin assays. Clin Chem 33:630–631
Bayer MF, Macoviak JA, McDougall IR (1987) Diagnostic performance of sensitive measurements of serum thyrotropin during severe non-thyroidal illness: their role in the diagnosis of hyperthyroidism. Clin Chem 33:2178–2184
Beierwaltes WH (1986a) Carcinoma of the thyroid: radionuclide diagnosis, therapy and follow-up. Clin Oncol 5:23–31
Beierwaltes WH (1986b) Natural history of thyroid cancer. In: Ingbar SH, Braverman LE (dds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1319–1328
Berghout A, Wiersinga WM, Smits NJ, Tubert JL (1987) Determinants of thyroid volume as measured by ultrasonography in healthy adults in a non-iodine deficient area. Clin Endocrinol 26:273–280
Biersack HJ, Winkler C (1982) Neue Aspekte in Diagnostik und Therapie des Schilddrüsenkarzinoms. Schattauer, Stuttgart
Biersack HJ, Helpapp B, Koch U, Janson R, Baumgarten C, Winkler C (1983a) Should treatment of highly differentiated thyroid carcinoma be conservative? Nucl Med 22:20–23
Biersack HJ, Albrecht W, Oehr P, Rasche A, Winkler C (1983b) Ermittlung der optimalenl-Thyroxin-Dosis zur Behandlung der blanden Struma. Dtsch Med Wochenschr 108:1269–1273
Bockisch A, Grünwald F, Ruhlmann J, Hotze A, Biersack HJ (1988) Bestimmung des basalen TSH-Spiegels mit einem supersensitiven IRMA — diagnostische Aussagekraft im Vergleich mit dem TRH-Test. Nucl Compact 19:19–26
Börner W, Refiners C (1987) Schilddrüsenmalignome — Diagnostik, Therapie and Nachsorge. Schattauer, Stuttgart
Bottermann P (1990) Strumatherapie mit Schilddrüsenhormonen oder Jodid? Inn Med 17:59–62
Braverman LE, Ingbar SH, Sterling K (1970) Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest 49:855–864
Brent GA, Hershman JM (1986) Effects of nonthyroidal illness on thyroid function tests. In: Van Middlesworth L (ed) The thyroid gland. Year Book, Chicago, p 83
Brent GA, Hershman JM, Braunstein GD (1986) Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med 81:463–466
Brinckner H, Hansen HR, Anderson AP (1973) Induction of leukaemia by131I treatment of thyroid carcinoma. Br J Cancer 28:232
Brunn J, Block U, Rough G, Bos I, Kunze WP, Scriba PC (1981) Volumetrie der Schilddrüsenlappen mittels Real-Time-Sonographie. Dtsch Med Wochenschr 106:1338–1340
Burger A, Dinichert D, Nicod P (1976) Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. J Clin Invest 58:255–260
Cady B, Rossi R (1988) An expanded view of risk-group definition on differentiated thyroid carcinoma. Surgery 104:947–953
Chopra IJ, Solomon DH, Hepner GW, Morganstein AA (1979) Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illness. Ann Intern Med 90:905–912
Cooper DS, Daniels GH, Ladenson PW, Ridgway EC (1982) Hyperthyroxinemia in patients treated with high-dose propranolol. Am J Med 73:867–871
De Vathaire F, Blanchon S, Schlumberger M (1988) Thyroglobulin level helps to predict recurrence after lobo-isthmusectomy in patients with differentiated thyroid carcinoma. Lancet I: 52–53
Doss DS, Neer RM, Ridgway EC, Daniels GO (1987) Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis withl-thyroxine. Am J Med 82:1167–1170
Dunn JR, Ray SC (1973) Changes in iodine metabolism and thyroglobulin structure in metastatic follicular carcinoma of the thyroid with hyperthyroidism. J Clin Endocrinol Metab 36:1088–1096
Dunn JT, Ray SC (1978) Variations in structure of thyroglobulin from normal and goitrous human thyroids. J Clin Endocrinol Metab 47:861–869
Ermans AM (1986) Endemic goiter. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 705–721
Evered D (1986) Subclinical hypothyroidism. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1439–1444
Friedman JM, Fialkow P (1986) Genetic factors in thyroid disease. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid —a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 634–650
Gärtner H (1990a) Pathophysiologie und Definition des Krankheitsbildes. In: Köbberling J, Pickardt CR (eds) Struma. Springer, Berlin Heidelberg New York, pp 7–13
Gärtner H (1990b) Sonographic. In: Köbberling J, Pickardt CR (eds) Struma. Springer, Berlin Heidelberg New York, pp 65–73
Gorman CA (1986) Extrathyroid manifestations of Graves' disease. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid —a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1015–1038
Grant CS, Hay ID, Gough IR, Bergstrahl EJ, Goellner JR, McConahey WM (1988) Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104:954–962
Gruhn JG, Barsano CP, Kumar Y (1987) The development of tests of thyroid function. Arch Pathol Lab Med 111:84–87
Gutekunst R (1990) Zytologie. In: Köbberling J, Pickardt CR (eds) Struma. Springer, Berlin Heidelberg New York
Gutekunst R, Scriba PC (1989) Goiter and iodine deficiency in Europe. The ETA report as updated in 1988. J Endocrinol Invest 12:209–215
Gutekunst R, Smolarek H, Wächter W, Scriba PC (1985) Strumaepidemiologie. IV. Schilddrüsenvolumina bei deutschen und schwedischen Schulkindern. Dtsch Med Wochenschr 109:50–54
Gutekunst R, Smolarek H, Hasenpusch U, Stubbe P, Friedrich HJ, Wood WG, Sriba PC (1986) Goiter epidemiology: thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) 112:494–501
Hamburger JI (1975) Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations. Am J Med 58: 740–749
Hamburger JL, Meier DA, Szpunar WE (1985) Factitious elevation of thyrotropin in cuthyroid patients. N Engl J Med 313:267–268
Hamming JF, Schelfhout LJDM, Cornelisse CJ, Van De Velde CJH, Goslings BM, Hermans J, Fleuren GJ (1988) Prognostic value of nuclear DNA content in papillary and follicular thyroid cancer. World J Surg 12:503–508
Hay ID, Grant CS, Taylor WF, McConahey WM (1987) Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 103:1088–1095
Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911
Hegedüs L, Perrild A, Poulsen LR, Anderson JR, Holm B, Schnohr D, Jensen G, Hansen JM (1983) The determination of thyroid volume by ultrasound and its relationship to body weight, age and sex in normal subjects. J Clin Endocrinol Metab 56:260–263
Hehrmann R (1991) Allgemeines Vorgehen mit Verlaufskontrolle bei Struma mit Hypothyreose. In: Börner W, Weinheimer B (eds) Schilddruse 1989 — primäre Diagnostik and Verlaufskontrolle der Struma. De Gruyter, Berlin, pp 407–416
Herle Van AJ (1985) Circulating thyroglobulin in thyroid cancer. In: Eggo MC, Burrow GN (eds) Thyroglobulin — the prothyroid hormone. Raven, New York, p 317
Herle Van AJ, Uller RP, Matthews NL, Brown J (1973) Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320–1327
Herle Van AJ (1985) Circulating thyroglobulin in thyroid cancer. In: Eggo MC, study evaluating serum thyroglobulin standards. J Clin Endocrinol Metab 60:338–343
Higgins HP, Bald E, Eastham S (1973) 20-min Tc-99m thyroid uptake. A simplified method using the gamma camera. J Nucl Med 14:907–911
Hintze G, KöbberlingJ (1987) Iodine vs thyroxine. A changing concept of therapy in endemic goiter? Klin Wochenschr 65:583–591
Hoie J, Stenwig AE, Kullmann G, Lindegaard M (1988) Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer 61:1–6
Hollander CS, Odak VV, Prout TE, Asper SP Jr (1962) An evaluation of the role of prealbumin in the binding of thyroxine. J Clin Endocrinol Metab 22:617–622
Horster FA, Klusmann G, Wildmeister W (1975) Der Kropf: Eine endemische Krankheit in der Bundesrepublik? Dtsch Med Wochenschr 100:8–9
Hotze A, Bockisch A, Horst M, Grünwald F, Ruhlmann J, Ammari B, Biersack HJ (1988) Vergleich der Wirksamkeit von reinem Levo-Thyroxin und einem Levo-Thyroxin-Jodid-Kombinationspräparat in der Therapie der blanden Struma. Nucl Compact 19:154–159
Hotze A, Bockisch A, Briele B, Horst M, Ruhlmann J, Biersack HJ (1989) Therapie der Jodmangelstruma mit Levothyroxin und einer Kombination aus Jodid und Levothyroxin. Nucl Compact 20:166–170
Hüfner M, Reiners C (eds) (1987) Thyroglobulin and thyroglobulin antibodies in the follow-up of thyroid cancer and endemic goiter. Georg Thieme, Stuttgart
Joseph K (1979) Statische, dynamische und quantifizierte Schilddrüsenszintigraphie. Nuklearmediziner 2:83–101
Joseph K (1991) Allgemeines zur funktionellen thyreoidalen Autonomie. In: Börner W, Weinheimer B (eds) Schilddrüse 1989 — primare Diagnostik and Verlaufskontrolle der Struma. De Gruyter, Berlin, pp 174–201
Kaplan MM, Larsen PR, Crantz FR (1982) Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med 72:9–16
Kapstein EJM, Robinson WJ, Grieb DA, Nicoloff JT (1982) Peripheral serumthyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illness. J Clin Invest 69:526–535
Kim PS, Dunn AD, Dunn JT (1988) Altered immunoreactivity of thyroglobulin in thyroid disease. J Clin Endocrinol Metab 67:161–168
Kohno Y, Tarutani O, Sakata S, Nakajima H (1985) Monoclonal antibodies to thyroglobulin elucidate differences in protein structure of thyroglobulin in healthy individuals and those with papillary adenocarcinoma. J Clin Endocrinol Metab 61:343–350
Krüskemper AL, Joseph K, Köbberling J, Reinwein D, Schatz H, Seif FJ (1985) Klassifikation der Schilddrusenkrankheiten. Neue Fassung der “Empfehlungen der Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie” Int Welt 8:47–49
Lamas L, Anderson PA, Fox JW, Dunn JT (1987) Early iodination sites of thyroglobulin. Ann D'Endocrinol 48: abstr 62
Lundberg PA, Jagenburg R, Lindstedt G, Nystrom E (1982) Heparin in vivo effect on free thyroxin. Clin Chem 28:1241–1248
Mahlstedt J (1986) Statische und dynamische Schilddrüsenszintigraphie. Nuklearmediziner 9:15–26
Mahlstedt J, Hotze A (1985) Erste Erfahrungen mit einem ultrasensitiven Immunradiometrischen TSH-Assay. Nucl Compact 16:72–76
Mazzaferri EL (1986) Treatment of carcinoma of follicular epithelium. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1329–1348
Melvin KE (1986) Medullary carcinoma of the thyroid. In: Ingbar SH, Braverman LE (ed) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1349–1362
Mendel CM, Cavalieri RR (1984) Thyroxine distribution and metabolism in familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab 59:499–504
Mendel CM, Frost PH, Kunitake S, Cavalieri RR (1987) Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. J Clin Endocrinol Metab 6:1259–1264
Moses AC, Lawlor J, Haddow J, Jackson IMD (1982) Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine-binding prealbumin. N Engl J Med 306:966–969
Paul T, Kerrigan J, Braverman LE, Baran D (1987) Long-terml-thyroxine therapy is associated with decreased femoral neck bone density in premenopausal women. Clin Res 35:648A (abstr)
Pearce CJ, Himsworth RL (1984) Total and free thyroid hormone concentrations in patients receiving maintenance replacement treatment with thyroxine. Br Med J 288:693–695
Pfannenstiel P (1985) Schilddrüsenkrankheiten — Diagnose und Therapie. Grosse, Berlin
Pfannenstiel P (1988) Therapie der endemischen Struma mit Levothyroxin und Jodid -Ergebnisse einer multizentrischen Studie. Dtsch Med Wochenschr 113:326–331
Pfannenstiel P (1989) Therapie mit Jodid und Schilddrüsenhormonen bei Schwangeren, Neugeborenen und Kindern. Pediatr Prax 39:497–502
Pfannenstiel P, Colbow B (1990) Schilddrüsenkrankheiten in der Schwangerschaft. Gynäkologe 23:47–52
Pickardt CR (1990) Symptome und klinische Befunde. In: Köbberling J, Pickardt CR (eds) Struma. Springer, Berlin Heidelberg New York, pp 37–40
Pinchera A, Bartalena L, Chiovato L, Marcocci C (1984) Radio therapy of Graves' ophthalmopathy. In: Gormann CA, Waller RR, Dyer JA (eds) The eye and orbit in thyroid disease. Raven, New York, pp 301–311
Rawitch AB, Gregg J, Turner DC (1985) Nature and location of hormonogenic sites within the structure of thyroglobulin. In: Eggo MC, Burrow GN (eds) Thyroglobulin — the prothyroid hormone. Raven, New York, p 43
Refetoff S (1982) Syndromes of thyroid hormone resistance. Am J Physiol 243: E88
Riesco G, Tavrog A, Larsen PR, Krulich L (1977) Acute and chronic responses to iodine deficiency in rats. Endocrinology 100:303–313
Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS (1987) Thyroid failure in the elderly. Microsomal antibodies as discriminate for therapy. JAMA 258:209–215
Ros DS (1986) New sensitive immunoradiometric assays for thyrotropin. Ann Intern Med 104:718–721
Sakata S, Nakamura S, Miura K (1985) Autoantibodies against thyroid hormones on iodothyronine. Ann Intern Med 103:579–589
Schelhout LJD, Creutzberg CL, Harming JF, Fleuren GJ, Smeenk D, Hermans J, Van de Velde CJH, Coslings BM (1988) Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer 24: 331–337
Schicha A, Emrich D (1983) Immunogene and nicht-immunogene Hyperthyreose. Dtsch Med Wochenschr 108:6–11
Schicha H, Emrich D (1990) Schilddrüsenszintigraphie — ist sie noch zeitgemäß? Dtsch Arztebl 87:A4024–4030
Schlumberger M, Fragu P, Paramentier C, Tubiana M (1981) Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its values in patients with or without normal residual tissue. Acta Endocrinol 98:215–221
Schlumberger M, Travagli JP, Fragu P, Gardet P, Lumbroso J, Parmentier C (1988a) Follow-up of patients with differentiated thyroid carcinoma. Experience at Institut Gustave-Roussy, Villejuif. Eur J Cancer 24:345–350
Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C (1988b) Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-ray. J Nucl Med 29:1790–1794
Schneider AB, Line BR, Goldmann JM, Robbins J (1981) Sequential serum thyroglobulin determinations on131I scans and131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab 53:1199–1206
Shimmins J, Alexander WD, McLarty DG (1971) 99m-Tc pertechnetate for measuring thyroid suppressibility. J Nucl Med 12:51–54
Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK (1988) Papillary and follicular thyroid cancer: impact of treatment in 1587 patients. Int J Radiat Oncol Biol Phys 14:1063–1075
Smith SA, Hay ID, Goellner JR, Ryan JJ, McConahey WM (1988) Mortality from papillary thyroid carcinoma. A case-control study of 56 lethal cases. Cancer 62:1381–1388
Solomon DH (1986) Treatment of Graves' hyperthyroidism. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 987–1014
Spencer CA, Lai Rosenfeld AO, Guttler R (1986) Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay. J Clin Endocrinol Metab 63:349–355
Staeheli V, Vallotton MB, Burger A (1975) Detection of human anti-thyroxine and anti-triiodothyronine antibodies in different thyroid conditions. J Clin Endocrinol Metab 41:669–675
Stanbury JB, Hetzel BS (1980) Endemic goiter and endemic cretinism. John Wiley, New York
Stäubli M, Bischof P, Wimpfheimer C, Studer H (1981) Amiodaron (Cordarone) and Schilddrüse. Schweiz Med Wochenschr 111:1590–1601
Stock JM, Surks MI, Oppenheimer JH (1974) Replacement dosage ofl-thyroxine in hypothyroidism. N Engl J Med 290:529–533
Struve C, Hinrichs J (1989) Schilddrüsenvolumina und Häufigkeit herdförmiger Veränderungen bei schilddrüsengesunden Männern und Frauen verschiedener Altersklassen. Dtsch Med Wochenschr 114:283–287
Toft AD (1985) Thyroxine replacement treatment: clinical judgment or biochemical control? Br Med J 291:233–324
Valimaki M, Lamberg BA (1985) How to deal with undetectable and low measurable serum thyroglobulin levels in the follow-up of patients with differentiated thyroid carcinoma? Acta Endocrinol 110:487–492
Volpé R (1986) Subacute thyroiditis. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1106–1119
Walfish PG (1986) Miscellaneous tumors of the thyroid. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid – a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 1363–1376
Wartofsky L, Burmann K (1982) Alterations in thyroid function in patients with systemic illness: the euthyroid sick syndrome. Endocrinol Rev 3:164–171
Woeber KA (1986) Graves' disease — general considerations. In: Ingbar SH, Braverman LE (eds) Werner's the thyroid — a fundamental and clinical text, 5th edn. Lippincott, Philadelphia, pp 982–986
Zarbransky S (1980) Langfristige Therapie-Überwachung bei Kindern mit Hypothyreose. Extr Med Pract 1:379–389
Zimmermann D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Gran CS, McConahey WM (1988) Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at our institution during three decades. Surgery 104:1157–1166
Author information
Authors and Affiliations
Additional information
Offprint requests to: H.J. Biersack
Rights and permissions
About this article
Cite this article
Biersack, H.J., Hotze, A. The clinician and the thyroid. Eur J Nucl Med 18, 761–778 (1991). https://doi.org/10.1007/BF00956719
Issue Date:
DOI: https://doi.org/10.1007/BF00956719